Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guarneri

Showing results (1371-1380 of 1,433) with videos related to

Pageof 144
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 13, 2020
Sharing real-world experiences to optimize the management of olaparib toxicities: a practical guidance from an Italian expert panelDomenica Lorusso, Alessandra Bologna, Sabrina Chiara Cecere, et al.
Scientific Reports|April 7, 2022
Phylogeography and genomic epidemiology of SARS-CoV-2 in Italy and Europe with newly characterized Italian genomes between February-June 2020Alessia Lai, Annalisa Bergna, Stefano Toppo, et al.
Dermatology Practical & Conceptual|March 30, 2026
CORONATE: A Novel Questionnaire to Assess the Long-Term Impact of Psoriasis on Patients' LivesStefano Piaserico, Francesca Sampogna, Martina Accorinti, et al.
Dermatology and Therapy|July 3, 2025
Guselkumab Retention, Effectiveness, and Safety in Psoriasis: A 260-Week Real-World Multicenter Retrospective Study Exploring the Role of Concomitant PsA-IL PSO (Italian Landscape Psoriasis)Mario Valenti, Luciano Ibba, Sara Di Giulio, et al.
Journal of Clinical Medicine|May 27, 2023
Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: An Expert Delphi Consensus StatementMaria Concetta Fargnoli, Federico Bardazzi, Luca Bianchi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 9, 2025
Real-world effectiveness comparison of first-line palbociclib, ribociclib or abemaciclib plus endocrine therapy in advanced HR-positive/HER2-negative BC patients: results from the multicenter PALMARES-2 studyL Provenzano, M V Dieci, G Curigliano, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|October 18, 2011
Italian Euromelanoma Day Screening Campaign (2005-2007) and the planning of melanoma screening strategiesStefania Seidenari, Elisa Benati, Giovanni Ponti, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 12, 2022
Moderate-to-severe atopic dermatitis in adolescents treated with dupilumab: A multicentre Italian real-world experienceL Stingeni, L Bianchi, E Antonelli, et al.
Clinical and Experimental Dermatology|November 1, 2025
Cumulative clinical benefits of biologic treatments in patients with moderate-to-severe psoriasis: an Italian real-life experience - IL PSO (Italian Landscape Psoriasis)Diego Orsini, Luca Potestio, Maria Concetta Fargnoli, et al.
Critical Reviews in Oncology/Hematology|June 8, 2025
The evolving landscape of hormone receptor-positive/HER2-negative metastatic breast cancer (EVOLVE): An Italian Delphi consensus reportFederica Miglietta, Maria Grazia Razeti, Aldo Caltavituro, et al.
Pageof 144

Showing results (1371-1380 of 1,433) with videos related to

Sort By:
Pageof 144
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 13, 2020
Sharing real-world experiences to optimize the management of olaparib toxicities: a practical guidance from an Italian expert panelDomenica Lorusso, Alessandra Bologna, Sabrina Chiara Cecere, et al.
Scientific Reports|April 7, 2022
Phylogeography and genomic epidemiology of SARS-CoV-2 in Italy and Europe with newly characterized Italian genomes between February-June 2020Alessia Lai, Annalisa Bergna, Stefano Toppo, et al.
Dermatology Practical & Conceptual|March 30, 2026
CORONATE: A Novel Questionnaire to Assess the Long-Term Impact of Psoriasis on Patients' LivesStefano Piaserico, Francesca Sampogna, Martina Accorinti, et al.
Dermatology and Therapy|July 3, 2025
Guselkumab Retention, Effectiveness, and Safety in Psoriasis: A 260-Week Real-World Multicenter Retrospective Study Exploring the Role of Concomitant PsA-IL PSO (Italian Landscape Psoriasis)Mario Valenti, Luciano Ibba, Sara Di Giulio, et al.
Journal of Clinical Medicine|May 27, 2023
Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: An Expert Delphi Consensus StatementMaria Concetta Fargnoli, Federico Bardazzi, Luca Bianchi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 9, 2025
Real-world effectiveness comparison of first-line palbociclib, ribociclib or abemaciclib plus endocrine therapy in advanced HR-positive/HER2-negative BC patients: results from the multicenter PALMARES-2 studyL Provenzano, M V Dieci, G Curigliano, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|October 18, 2011
Italian Euromelanoma Day Screening Campaign (2005-2007) and the planning of melanoma screening strategiesStefania Seidenari, Elisa Benati, Giovanni Ponti, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 12, 2022
Moderate-to-severe atopic dermatitis in adolescents treated with dupilumab: A multicentre Italian real-world experienceL Stingeni, L Bianchi, E Antonelli, et al.
Clinical and Experimental Dermatology|November 1, 2025
Cumulative clinical benefits of biologic treatments in patients with moderate-to-severe psoriasis: an Italian real-life experience - IL PSO (Italian Landscape Psoriasis)Diego Orsini, Luca Potestio, Maria Concetta Fargnoli, et al.
Critical Reviews in Oncology/Hematology|June 8, 2025
The evolving landscape of hormone receptor-positive/HER2-negative metastatic breast cancer (EVOLVE): An Italian Delphi consensus reportFederica Miglietta, Maria Grazia Razeti, Aldo Caltavituro, et al.
Pageof 144